跳至主要内容
临床试验/KCT0003872
KCT0003872已完成未知

A human study to evaluate the effect and the safety of GUCO on blood triglyceride levels

Inha University Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 0No Limit(—)
性别
All

入选标准

  • 1) Subject who voluntarily agree to participate and signs informed consent form
  • 2) Men and women over 20 years old (ratio of men and women 1:1)
  • 3) 150 mg/dL =Blood triglyceride levels <200 mg/d

排除标准

  • 1) Excessive exercise (= 10 hours/week)
  • 2) Heavy smoking (= 20 cigarettes/day)
  • 3) Alcoholism or alcohol consumption more than 420g/week (soju 7 bottles/week)
  • 4) BMI (Body Mass Index) <20.0 kg/m2 or =35.0 kg/m2
  • 5) Recommended food score >36
  • 6) Following diseases
  • : hyperlipidemia, diabetes, hypertension, liver disease, intestinal disease(inflammatory disease, lactose intolerance, etc), renal disease, cardiovascular disease, cerebrovascular disease, pancreatitis, cancer, thyroid disease, dementia, Parkinson's disease, depression, anorexia/bulimia, multiple sclerosis, spine injury, hypokalemia, uerine disease, etc.
  • 7) Following medicines within 1 month before the first visit or during study,
  • : lipid-lowering agents(ursodeoxycholic acid), statin, etc), blood glucose-lowering drugs, antibiotics, drugs on intestine function, hormones, oral contraceptives, appetite depressants/stimulant, diuretics, beta-blockers, contraceptives, steroids, tricyclic antidepressants, laxatives, antidepressants, et al. But subjects taking thiazide or beta-blockers with no dose change for 1 year and during study can be enrolled.
  • 8) Continuous consumption of oriental herbal medicine within 1 month before the first visit
  • 9) Continuous consumption of dietary supplements with efficacy on blood lipids, blood glucose, body fat metabolism within 1 month before the first visit (phytosterol, omega-3 fatty acids, psyllium husk, aloe, chitosan, onion extract, nondigestible maltodextrin, dietary fiber, etc)
  • 10) Subjects with hypersensitivity to test materials
  • 11) Participation in other human study within one month before the first visit
  • 12) Pregnant or lactating women
  • 13) Any condition that the principal investigator believes may put the subjects at undue risk

研究者

相似试验